Raymond James & Associates’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-23,696
Closed -$71 4019
2023
Q4
$71 Buy
+23,696
New +$71 ﹤0.01% 3766
2021
Q3
Sell
-10,600
Closed -$32K 4072
2021
Q2
$32K Hold
10,600
﹤0.01% 3857
2021
Q1
$35K Sell
10,600
-125
-1% -$413 ﹤0.01% 3783
2020
Q4
$44K Buy
+10,725
New +$44K ﹤0.01% 3566